Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-10-07 23:04 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Croatia · Czechia · Germany · Hungary · Japan · Latvia · Poland · Puerto Rico · Slovakia · South Africa · Ukraine · United Arab Emirates · United States
Registry dates and results
Start: 2016-08-10. Completion: 2018-03-30 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
semaglutide (drug)
liraglutide (drug)
placebo (drug)
Where the study takes place — 108 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Start: 2011-12. Completion: 2016-12 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
GLP-1 (Liraglutide) (drug) — also listed as: Victoza
Placebo (drug) — also listed as: PL1 PR1
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University Medical Center Hamburg Hamburg, Germany Site recruitment: Not reported
Start: 2017-11-29. Completion: 2021-08-31 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide (drug) — also listed as: Saxenda, Victoza
Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Mayo Clinic in Rochester Rochester, Minnesota, United States Site recruitment: Not reported
Start: 2014-02. Completion: 2022-06 (may be estimated). No results posted in this registry response.
Products and interventions (5)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Roux-en-Y Gastric Bypass (RYGB) (procedure)
Incretin analogues (drug) — also listed as: Liraglutide
Xenical (drug) — also listed as: Orlistat
SGLT2 inhibitors (drug) — also listed as: Empagliflozin, Canagliflozin
DPP-4 Inhibitors (drug) — also listed as: Sitagliptin, Linagliptin
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Khoo Teck Puat Hospital Singapore, Singapore Site recruitment: Not reported
Start: 2019-03-07. Completion: 2022-05-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide 6 MG/ML (drug)
Colesevelam (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Gentofte Hospital Hellerup, Regionh, Denmark Site recruitment: Not reported
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The third hospital affiliated to the Third Military Medical University Chongqing, Chongqing Municipality, China Site recruitment: Not reported
Start: 2015-02-01. Completion: 2019-02-28 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide (drug) — also listed as: Victoza
Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Helsinki University Central Hospital Helsinki, Finland Site recruitment: Not reported
Canada · Estonia · Germany · Israel · Italy · Romania · Slovakia · Spain · United States
Registry dates and results
Start: 2016-07-06. Completion: 2018-11-17 (may be estimated). Results are posted in this registry.
Products and interventions (7)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Insulin glargine/lixisenatide fixed ratio combination (drug) — also listed as: HOE901/AVE0010, Soliqua
liraglutide (drug) — also listed as: Victoza
exenatide (drug) — also listed as: Byetta
exenatide extended-release (drug) — also listed as: Bydureon
albiglutide (drug) — also listed as: Tanzeum
dulaglutide (drug) — also listed as: Trulicity
Background therapy: Oral Anti-diabetic Drug (Metformin, Pioglitazone, SGLT2 inhibitor) (drug)
Where the study takes place — 124 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Investigational Site Number 8400064 Birmingham, Alabama, United States Site recruitment: Not reported
Investigational Site Number 8400073 Fountain Hills, Arizona, United States Site recruitment: Not reported
Investigational Site Number 8400047 Phoenix, Arizona, United States Site recruitment: Not reported
Investigational Site Number 8400103 Bakersfield, California, United States Site recruitment: Not reported
Investigational Site Number 8400137 Fresno, California, United States Site recruitment: Not reported
Investigational Site Number 8400043 Huntington Park, California, United States Site recruitment: Not reported
Investigational Site Number 8400124 Lamont, California, United States Site recruitment: Not reported
Investigational Site Number 8400027 Lancaster, California, United States Site recruitment: Not reported
Investigational Site Number 8400098 Los Angeles, California, United States Site recruitment: Not reported
Investigational Site Number 8400013 Los Angeles, California, United States Site recruitment: Not reported
Investigational Site Number 8400042 Mission Hills, California, United States Site recruitment: Not reported
Investigational Site Number 8400006 Northridge, California, United States Site recruitment: Not reported
Investigational Site Number 8400021 Orange, California, United States Site recruitment: Not reported
Investigational Site Number 8400126 Rialto, California, United States Site recruitment: Not reported
Investigational Site Number 8400094 Santa Ana, California, United States Site recruitment: Not reported
Canada · Czechia · Germany · Hungary · Mexico · Russia · Spain · United States
Registry dates and results
Start: 2016-12-02. Completion: 2017-12-27 (may be estimated). Results are posted in this registry.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
SAR425899 (drug)
Placebo (drug)
Liraglutide (drug) — also listed as: Victoza
Metformin (drug)
Where the study takes place — 59 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Investigational Site Number 8400028 Sheffield, Alabama, United States Site recruitment: Not reported
Investigational Site Number 8400002 Huntington Park, California, United States Site recruitment: Not reported
Investigational Site Number 8400024 Los Angeles, California, United States Site recruitment: Not reported
Investigational Site Number 8400001 Los Angeles, California, United States Site recruitment: Not reported
Investigational Site Number 8400012 Port Hueneme, California, United States Site recruitment: Not reported
Investigational Site Number 8400027 Denver, Colorado, United States Site recruitment: Not reported
Investigational Site Number 8400025 Miami, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400007 Palm Harbor, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400013 Chicago, Illinois, United States Site recruitment: Not reported
Investigational Site Number 8400016 Wichita, Kansas, United States Site recruitment: Not reported
Investigational Site Number 8400023 Wichita, Kansas, United States Site recruitment: Not reported
Investigational Site Number 8400018 New Orleans, Louisiana, United States Site recruitment: Not reported
Investigational Site Number 8400019 Rockville, Maryland, United States Site recruitment: Not reported
Investigational Site Number 8400014 Flint, Michigan, United States Site recruitment: Not reported
Investigational Site Number 8400003 Troy, Michigan, United States Site recruitment: Not reported
Investigational Site Number 8400020 Linden, New Jersey, United States Site recruitment: Not reported
Investigational Site Number 8400022 New York, New York, United States Site recruitment: Not reported
Investigational Site Number 8400005 Fargo, North Dakota, United States Site recruitment: Not reported
Investigational Site Number 8400004 Austin, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400006 Dallas, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400021 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400026 San Antonio, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400017 Sugar Land, Texas, United States Site recruitment: Not reported
Investigational Site Number 1240008 Québec, Canada Site recruitment: Not reported
Investigational Site Number 1240005 Sainte-Foy, Canada Site recruitment: Not reported
Investigational Site Number 1240002 Sherbrooke, Canada Site recruitment: Not reported
Investigational Site Number 1240001 Toronto, Canada Site recruitment: Not reported
Investigational Site Number 1240003 Vancouver, Canada Site recruitment: Not reported
Investigational Site Number 2030003 České Budějovice, Czechia Site recruitment: Not reported
Investigational Site Number 2030001 Krnov, Czechia Site recruitment: Not reported
Investigational Site Number 2030004 Praha 10 - Uhrineves, Czechia Site recruitment: Not reported
Investigational Site Number 2030002 Praha 9 - Klanovice, Czechia Site recruitment: Not reported
Investigational Site Number 2760003 Berlin, Germany Site recruitment: Not reported
Investigational Site Number 2760001 Dresden, Germany Site recruitment: Not reported
Investigational Site Number 2760006 Hohenmölsen, Germany Site recruitment: Not reported
Investigational Site Number 3480001 Balatonfüred, Hungary Site recruitment: Not reported
Investigational Site Number 3480002 Budapest, Hungary Site recruitment: Not reported
Investigational Site Number 3480008 Budapest, Hungary Site recruitment: Not reported
Investigational Site Number 3480005 Budapest, Hungary Site recruitment: Not reported
Investigational Site Number 3480006 Budapest, Hungary Site recruitment: Not reported
Investigational Site Number 3480007 Budapest, Hungary Site recruitment: Not reported
Investigational Site Number 4840004 Actopan, Mexico Site recruitment: Not reported
Investigational Site Number 4840001 Guadalajara, Mexico Site recruitment: Not reported
Investigational Site Number 4840003 Guadalajara, Mexico Site recruitment: Not reported
Investigational Site Number 4840002 Monterrey, Mexico Site recruitment: Not reported
Investigational Site Number 4840006 San Juan del Río, Mexico Site recruitment: Not reported
Investigational Site Number 6430002 Saint Petersburg, Russia Site recruitment: Not reported
Investigational Site Number 6430004 Saint Petersburg, Russia Site recruitment: Not reported
Investigational Site Number 6430001 Saint Petersburg, Russia Site recruitment: Not reported
Investigational Site Number 6430003 Saratov, Russia Site recruitment: Not reported
Investigational Site Number 6430005 Voronezh, Russia Site recruitment: Not reported
Investigational Site Number 7240001 A Coruña, Spain Site recruitment: Not reported
Investigational Site Number 7240005 Barcelona, Spain Site recruitment: Not reported
Investigational Site Number 7240007 Ferrol, Spain Site recruitment: Not reported
Investigational Site Number 7240006 Las Palmas de Gran Canaria, Spain Site recruitment: Not reported
Investigational Site Number 7240002 Madrid, Spain Site recruitment: Not reported
Investigational Site Number 7240003 Málaga, Spain Site recruitment: Not reported
Investigational Site Number 7240004 Málaga, Spain Site recruitment: Not reported
Investigational Site Number 7240008 Seville, Spain Site recruitment: Not reported
Start: 2020-06-22. Completion: 2020-11-27 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide injection,RD12014 (drug)
Liraglutide injection,Victoza (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Shanghai Xuhui Central Hospital Shanghai, Shanghai Municipality, China Site recruitment: Not reported
General Committee of Teaching Hospitals and Institutes, Egypt
Countries with listed sites
Egypt
Registry dates and results
Start: 2022-03-10. Completion: 2022-09 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide Pen Injector [Saxenda] (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Madina Women's Hospital Alexandria, Egypt Site recruitment: Not reported
Type 2 Diabetes Treated With Insulin; Obesity; Adolescent Obesity
Sponsor
Corporacion Parc Tauli
Countries with listed sites
Pakistan
Registry dates and results
Start: 2020-01-02. Completion: 2021-11-20 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Dulaglutide (drug) — also listed as: Group DUL
Liraglutide (drug) — also listed as: Group LIR
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Zainab Khan Lahore, Punjab Province, Pakistan Site recruitment: Not reported
Start: 2013-11-07. Completion: 2014-10-03 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
MK-8521 (drug)
Liraglutide (drug)
Placebo (drug)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2022-01-27. Completion: 2023-01-27 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide (drug) — also listed as: Endoscopic ultrasound
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Specialized Medical Hospital,Mansoura University Al Mansurah, Dakhlia, Egypt Site recruitment: Recruiting
MansouraU Al Mansurah, Egypt Site recruitment: Recruiting
Start: 2021-07-16. Completion: 2021-08-19 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide injection (drug)
Liraglutide injection(Victoza®) (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Phase I Clinical Research Center Qingdao, Shandong, China Site recruitment: Not reported
Start: 2016-03. Completion: 2021-06 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Victoza® (drug)
Placebo (drug)
Where the study takes place — 4 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Oulu and Oulu University Hospital, Dept of Children and Adolescents Oulu, Finland Site recruitment: Not reported
University of Tampere and Tampere University Hospital Tampere, Finland Site recruitment: Not reported
University of Turku and Turku University Hospital Turku, Finland Site recruitment: Not reported
Lund University and Skåne University Hospital Malmö, Sweden Site recruitment: Not reported
Start: 2015-12. Completion: 2024-06 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Victoza® (drug)
Placebo (drug)
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Oulu and Oulu University Hospital Oulu, Finland Site recruitment: Not reported
University of Tampere and Tampere University Hospital Tampere, Finland Site recruitment: Not reported
University of Turku and Turku University Hospital Turku, Finland Site recruitment: Not reported
Start: 2018-08-15. Completion: 2021-11-09 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide (drug) — also listed as: Victoza
Golimumab (drug) — also listed as: SIMPONI
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States Site recruitment: Not reported
Benaroya Research Institute Seattle, Washington, United States Site recruitment: Not reported
Fatty Liver, Nonalcoholic; Diabetes Mellitus, Type 2
Sponsor
Alexandria University
Countries with listed sites
Egypt
Registry dates and results
Start: 2021-02-23. Completion: 2022-09-30 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Metformin (drug) — also listed as: Liraglutide, empagliflozin, Vildagliptin
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Alexandria University. Alexandria, Egypt Site recruitment: Not reported
Start: 2016-03. Completion: 2021-05 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Victoza® (liraglutide) (drug)
Placebo (drug)
Where the study takes place — 4 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Oulu and Oulu University Hospital, Dept of Children and Adolescents Oulu, Finland Site recruitment: Not reported
University of Tampere and Tampere University Hospital Tampere, Finland Site recruitment: Not reported
University of Turku and Turku University Hospital Turku, Finland Site recruitment: Not reported
Lund University and Skåne University Hospital Malmö, Sweden Site recruitment: Not reported
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.
Investigational Site Number 8400009 Ventura, California, United States Site recruitment: Not reported
Investigational Site Number 8400071 Denver, Colorado, United States Site recruitment: Not reported
Investigational Site Number 8400036 Denver, Colorado, United States Site recruitment: Not reported
Investigational Site Number 8400114 Jacksonville, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400133 Miami, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400058 Port Charlotte, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400084 Tampa, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400112 West Palm Beach, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400045 Lawrenceville, Georgia, United States Site recruitment: Not reported
Investigational Site Number 8400096 Snellville, Georgia, United States Site recruitment: Not reported
Investigational Site Number 8400023 Springfield, Illinois, United States Site recruitment: Not reported
Investigational Site Number 8400049 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400053 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400085 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400120 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400041 Evansville, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400038 Indianapolis, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400130 Council Bluffs, Iowa, United States Site recruitment: Not reported
Investigational Site Number 8400034 Lexington, Kentucky, United States Site recruitment: Not reported
Investigational Site Number 8400091 Lexington, Kentucky, United States Site recruitment: Not reported
Investigational Site Number 8400078 Marrero, Louisiana, United States Site recruitment: Not reported
Investigational Site Number 8400032 Metairie, Louisiana, United States Site recruitment: Not reported
Investigational Site Number 8400088 New Orleans, Louisiana, United States Site recruitment: Not reported
Investigational Site Number 8400033 Baltimore, Maryland, United States Site recruitment: Not reported
Investigational Site Number 8400051 Jefferson City, Missouri, United States Site recruitment: Not reported
Investigational Site Number 8400083 Papillion, Nebraska, United States Site recruitment: Not reported
Investigational Site Number 8400044 Henderson, Nevada, United States Site recruitment: Not reported
Investigational Site Number 8400079 Albany, New York, United States Site recruitment: Not reported
Investigational Site Number 8400061 New York, New York, United States Site recruitment: Not reported
Investigational Site Number 8400123 North Massapequa, New York, United States Site recruitment: Not reported
Investigational Site Number 8400095 Staten Island, New York, United States Site recruitment: Not reported
Investigational Site Number 8400067 West Seneca, New York, United States Site recruitment: Not reported
Investigational Site Number 8400111 Yonkers, New York, United States Site recruitment: Not reported
Investigational Site Number 8400020 Morehead City, North Carolina, United States Site recruitment: Not reported
Investigational Site Number 8400065 Wilmington, North Carolina, United States Site recruitment: Not reported
Investigational Site Number 8400018 Fargo, North Dakota, United States Site recruitment: Not reported
Investigational Site Number 8400019 Columbus, Ohio, United States Site recruitment: Not reported
Investigational Site Number 8400056 Dayton, Ohio, United States Site recruitment: Not reported
Investigational Site Number 8400125 Mentor, Ohio, United States Site recruitment: Not reported
Investigational Site Number 8400099 Oklahoma City, Oklahoma, United States Site recruitment: Not reported
Investigational Site Number 8400129 Scottdale, Pennsylvania, United States Site recruitment: Not reported
Investigational Site Number 8400076 Smithfield, Pennsylvania, United States Site recruitment: Not reported
Investigational Site Number 8400104 Warwick, Rhode Island, United States Site recruitment: Not reported
Investigational Site Number 8400090 Columbia, South Carolina, United States Site recruitment: Not reported
Investigational Site Number 8400139 Austin, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400001 Dallas, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400118 Edinburg, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400008 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400109 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400063 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400106 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400014 North Richland Hills, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400089 San Antonio, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400135 Schertz, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400075 Shavano Park, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400107 Sugar Land, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400054 Orem, Utah, United States Site recruitment: Not reported
Investigational Site Number 8400025 Salt Lake City, Utah, United States Site recruitment: Not reported
Investigational Site Number 8400092 Weber City, Virginia, United States Site recruitment: Not reported
Investigational Site Number 1240003 Burlington, Canada Site recruitment: Not reported
Investigational Site Number 1240006 Corunna, Canada Site recruitment: Not reported
Investigational Site Number 1240002 Red Deer, Canada Site recruitment: Not reported
Investigational Site Number 1240001 Vancouver, Canada Site recruitment: Not reported
Investigational Site Number 2330002 Pärnu, Estonia Site recruitment: Not reported
Investigational Site Number 2330003 Tallinn, Estonia Site recruitment: Not reported
Investigational Site Number 2330001 Tallinn, Estonia Site recruitment: Not reported
Investigational Site Number 2330004 Viljandi, Estonia Site recruitment: Not reported
Investigational Site Number 2760001 Dresden, Germany Site recruitment: Not reported
Investigational Site Number 2760003 Oldenburg in Holstein, Germany Site recruitment: Not reported
Investigational Site Number 3760001 Haifa, Israel Site recruitment: Not reported
Investigational Site Number 3760002 Haifa, Israel Site recruitment: Not reported
Investigational Site Number 3760005 Jerusalem, Israel Site recruitment: Not reported
Investigational Site Number 3760006 Jerusalem, Israel Site recruitment: Not reported
Investigational Site Number 3760004 Tel Aviv, Israel Site recruitment: Not reported
Investigational Site Number 3800008 Bergamo, Italy Site recruitment: Not reported
Investigational Site Number 3800002 Bologna, Italy Site recruitment: Not reported
Investigational Site Number 3800001 Milan, Italy Site recruitment: Not reported
Investigational Site Number 3800006 Milan, Italy Site recruitment: Not reported
Investigational Site Number 3800005 Naples, Italy Site recruitment: Not reported
Investigational Site Number 3800004 Roma, Italy Site recruitment: Not reported
Investigational Site Number 3800003 Roma, Italy Site recruitment: Not reported
Investigational Site Number 6420004 Bacau, Romania Site recruitment: Not reported
Investigational Site Number 6420006 Brasov, Romania Site recruitment: Not reported
Investigational Site Number 6420001 Bucharest, Romania Site recruitment: Not reported
Investigational Site Number 6420008 Buzău, Romania Site recruitment: Not reported
Investigational Site Number 6420003 Cluj-Napoca, Romania Site recruitment: Not reported
Investigational Site Number 6420002 Oradea, Romania Site recruitment: Not reported
Investigational Site Number 6420009 Targoviste, Romania Site recruitment: Not reported
Investigational Site Number 6420007 Târgu Mureş, Romania Site recruitment: Not reported
Investigational Site Number 6420005 Timișoara, Romania Site recruitment: Not reported
Investigational Site Number 7030006 Bratislava, Slovakia Site recruitment: Not reported
Investigational Site Number 7030002 Lučenec, Slovakia Site recruitment: Not reported
Investigational Site Number 7030009 Ľubochňa, Slovakia Site recruitment: Not reported
Investigational Site Number 7030005 Malacky, Slovakia Site recruitment: Not reported
Investigational Site Number 7030007 Prešov, Slovakia Site recruitment: Not reported
Investigational Site Number 7030001 Rožňava, Slovakia Site recruitment: Not reported
Investigational Site Number 7030008 Sabinov, Slovakia Site recruitment: Not reported
Investigational Site Number 7030004 Trenčín, Slovakia Site recruitment: Not reported
Investigational Site Number 7030003 Žilina, Slovakia Site recruitment: Not reported
Investigational Site Number 7240012 Alzira, Spain Site recruitment: Not reported
Investigational Site Number 7240005 Barcelona, Spain Site recruitment: Not reported
Investigational Site Number 7240002 Ferrol, Spain Site recruitment: Not reported
Investigational Site Number 7240008 Málaga, Spain Site recruitment: Not reported
Investigational Site Number 7240011 Pozuelo de Alarcón, Spain Site recruitment: Not reported
Investigational Site Number 7240003 Quart de Poblet, Spain Site recruitment: Not reported
Investigational Site Number 7240006 Sabadell, Spain Site recruitment: Not reported
Investigational Site Number 7240007 Seville, Spain Site recruitment: Not reported
Investigational Site Number 7240009 Seville, Spain Site recruitment: Not reported
Investigational Site Number 7240004 Seville, Spain Site recruitment: Not reported
